↓ Skip to main content

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

Overview of attention for article published in New England Journal of Medicine, January 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Readers on

mendeley
1611 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 155 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 1,611 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 1 <1%
Kenya 1 <1%
Japan 1 <1%
Spain 1 <1%
Unknown 1607 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 205 13%
Other 155 10%
Student > Ph. D. Student 137 9%
Student > Master 112 7%
Student > Bachelor 87 5%
Other 285 18%
Unknown 630 39%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 530 33%
Chemistry 68 4%
Biochemistry, Genetics and Molecular Biology 66 4%
Physics and Astronomy 54 3%
Pharmacology, Toxicology and Pharmaceutical Science 40 2%
Other 166 10%
Unknown 687 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 635. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2026.
All research outputs
#44,216
of 34,665,430 outputs
Outputs from New England Journal of Medicine
#1,526
of 38,561 outputs
Outputs of similar age
#790
of 469,361 outputs
Outputs of similar age from New England Journal of Medicine
#32
of 259 outputs
Altmetric has tracked 34,665,430 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 38,561 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 120.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 469,361 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 259 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.